Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomatitis 2Neoplasms 2Thromboembolism 1Sarcoma 1Respiratory Insufficiency 1Prostatic Neoplasms 1Pneumonia 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Myocardial Infarction 1Mucositis 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Diseases 1Head and Neck Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Adenocarcinoma 1Acute Coronary Syndrome 1

Interventions

avelumab 2Sunitinib 2Nutrition Assessment 2Blood Specimen Collection 2Axitinib 2trifluridine tipiracil drug combination 1trebananib 1spartalizumab 1pembrolizumab 1etelcalcetide hydrochloride 1enzalutamide 1bicalutamide 1aldesleukin 1Stents 1Sorafenib 1Sodium Bicarbonate 1Resistance Training 1Receptors, Androgen 1Plasma Exchange 1Pharmaceutical Preparations 1Paclitaxel 1Oxaliplatin 1Nephrotomy 1Nephrostomy, Percutaneous 1Lysine Acetyltransferase 5 1Leuprolide 1Kidney Transplantation 1Interleukin-2 1Goserelin 1Flutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Kidney Diseases × Sodium Bicarbonate × Clear all
NCT00540904 2014-03-03

Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

Barretos Cancer Hospital

Phase 2 Completed
27 enrolled
Genitourinary

Kidney Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡